HAPPYMINI® IN THE HALLUX RIGIDUS

HAPPYMINI® IN THE HALLUX RIGIDUS   The ISIAT 2019 held in Lisbon in October was the occasion for LABRHA to present a study about HAppyMini® in the Hallux Rigidus (Osteoarthritis of the first metatarso-phalangeal joint). This prospective open-label multicentre pilot trial was conducted on 65 patients and safety was very good Read more…

Predictive factors of adherence to an association of glucosamine sulfate, copper, and ginger extracts in patients with symptomatic osteoarthritis: a prospective open-label French noninterventional study (the PREDOA study)

New Publication about Cuivramine® with the PREDOA Study conducted on more than 2000 patients Guidelines recommend symptomatic slow-acting drugs for OA (SYSADOA) to reduce pain and avoid the use of NSAIDs. However, the main issue with slow-acting treatments is the poor adherence. In this study, we could observe an excellent compliance, higher than expected with Read more…

HAPPYMINI® in the treatment of Temporo-Mandibular Osteoarthritis

  This prospective pilot study was conducted to show the Safety & Efficacy of a Single Injection of Mannitol-modified Cross-Linked Hyaluronic Acid (HAppyMini®) in the treatment of the Temporo-Mandibular Osteoartritis.   Results  at D180 : Treatment was efficient or very efficient for 94% of the patients Long lasting improvment of the inter-incisal distance  2/3 of patients reduced their painkillers Read more…